Patent · US Active

Composition and method for the diagnosis and treatment of diseases associated with neurite degeneration

US9102722B2 · kind B2 · utility

5Cited by

164References

5Claims

0Family size

Assignees

Abb Vie Deutschland Gmbh & Co. KG · DE
Abb Vie Inc. · US

Inventors

Bernhard Mueller · Neustadt, DE
Lili Huang · Westford, US
Philip Bardwell · Boston, US
Yuliya Kutskova · Northborough, US
John E. Memmott · Framingham, US

Key dates

Filing date	Sep 23, 2013
Grant date	Aug 11, 2015
Priority date	—
Expiry date	Sep 23, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/285
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are antibodies that bind to Repulsive Guidance Molecule a (RGMa) and methods of using the antibodies to treat and diagnose neurite degenerative diseases and disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.